The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(((2-bromopyridin-4-yl)oxy)methyl)-7-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide ID: ALA4533083
PubChem CID: 155547618
Max Phase: Preclinical
Molecular Formula: C19H13BrFN5O2
Molecular Weight: 442.25
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1cc(-c2ccc(F)cc2)n2nc(COc3ccnc(Br)c3)cc2n1
Standard InChI: InChI=1S/C19H13BrFN5O2/c20-17-8-14(5-6-23-17)28-10-13-7-18-24-15(19(22)27)9-16(26(18)25-13)11-1-3-12(21)4-2-11/h1-9H,10H2,(H2,22,27)
Standard InChI Key: VEIVGBLYCNEWTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
36.1788 -3.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8841 -3.3100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8841 -2.4928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1788 -2.0801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.4735 -3.3100 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.4690 -2.4929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6905 -2.2446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2138 -2.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6978 -3.5668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.5930 -2.0863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2995 -2.4970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.5954 -1.2691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.3966 -2.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9919 -3.6229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.1784 -4.5309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4690 -4.9389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4687 -5.7553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1769 -6.1647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8870 -5.7517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8838 -4.9366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1780 -6.9819 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.1747 -3.6274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7650 -2.9235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9486 -2.9277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5431 -3.6382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9600 -4.3459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7751 -4.3383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5579 -5.0573 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
6 4 1 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
3 10 1 0
10 11 1 0
10 12 2 0
8 13 1 0
13 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
1 15 1 0
18 21 1 0
14 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
26 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 442.25Molecular Weight (Monoisotopic): 441.0237AlogP: 3.37#Rotatable Bonds: 5Polar Surface Area: 95.40Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.86CX Basic pKa: 2.81CX LogP: 3.00CX LogD: 3.00Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.48Np Likeness Score: -1.57
References 1. Childress ES, Wieting JM, Felts AS, Breiner MM, Long MF, Luscombe VB, Rodriguez AL, Cho HP, Blobaum AL, Niswender CM, Emmitte KA, Conn PJ, Lindsley CW.. (2018) Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu2 ) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5- a]pyrimidine-5-carboxamide and Thieno[3,2- b]pyridine-5-carboxamide Cores., 62 (1): [PMID:30350962 ] [10.1021/acs.jmedchem.8b01266 ]